Filing Details

Accession Number:
0001209191-17-010534
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-02-14 17:20:52
Reporting Period:
2017-02-10
Filing Date:
2017-02-14
Accepted Time:
2017-02-14 17:20:52
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1429560 Trevena Inc TRVN Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1591564 W. Michael Lark C/O Trevena, Inc.
1018 West 8Th Avenue, Suite A
King Of Prussia PA 19406
Sr. Vp, Research & Cso No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-02-10 12,815 $0.68 98,460 No 4 M Direct
Common Stock Disposition 2017-02-10 23,699 $8.00 74,761 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (Right to Buy) Disposition 2017-02-10 12,815 $0.00 12,815 $0.68
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
48,362 2020-09-10 No 4 M Direct
Footnotes
  1. 12,815 of these shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 9, 2016 and 10,884 of these shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 23, 2016.
  2. Immediately exercisable.